Cellular Physiology

On this page

🔬 Cellular Command Center: The Membrane's Molecular Machinery

Every cell in your body maintains a precisely controlled internal environment despite constant external flux, and this feat depends entirely on molecular machines embedded in the plasma membrane. You'll discover how ion channels create electrical signals, how carrier proteins move nutrients against concentration gradients, and how these transport systems integrate to sustain life. When these mechanisms fail, diseases ranging from cystic fibrosis to cardiac arrhythmias emerge, making this knowledge essential for clinical reasoning. By mastering cellular transport, you'll understand how cells communicate, adapt, and survive-the foundation for every physiological process you'll encounter in medicine.

The Membrane's Architectural Blueprint

The plasma membrane represents cellular engineering at its finest, maintaining life through precise molecular control:

  • Lipid Bilayer Foundation

    • Phospholipid composition: 50-60% of membrane mass
    • Cholesterol content: 20-25% (modulates fluidity)
    • Membrane thickness: 7-10 nm with 2-3 nm hydrophobic core
      • Outer leaflet: phosphatidylcholine (45%), sphingomyelin (25%)
      • Inner leaflet: phosphatidylserine (15%), phosphatidylethanolamine (20%)
  • Protein Integration Systems

    • Integral proteins: 25-30% of membrane mass
    • Peripheral proteins: 5-10% of total membrane protein
    • Protein-to-lipid ratio varies: 1:50 (myelin) to 3:1 (mitochondrial inner membrane)

📌 Remember: FLIP - Fluidity Lipids Integral Proteins. Membrane fluidity decreases with cholesterol (>30% = rigid), increases with unsaturated fatty acids (>40% = leaky), and optimal function requires 20-25% cholesterol content.

Transport TypeEnergy SourceSelectivityRate (molecules/sec)Gradient DirectionClinical Example
Simple DiffusionConcentration gradientLow10³-10⁶Down gradientO₂, CO₂ exchange
Facilitated DiffusionConcentration gradientHigh10⁴-10⁶Down gradientGLUT1 glucose transport
Primary ActiveATP hydrolysisVery High10²-10⁴Against gradientNa⁺/K⁺-ATPase
Secondary ActiveIon gradientsHigh10³-10⁵Coupled transportSGLT1 glucose uptake
Vesicular TransportATP + GTPAbsolute10¹-10³BidirectionalInsulin secretion

💡 Master This: Every transport protein exhibits saturation kinetics with specific Km values. GLUT1 (Km = 1-2 mM) ensures constant glucose uptake even during fasting, while GLUT2 (Km = 15-20 mM) in pancreatic β-cells acts as a glucose sensor, triggering insulin release only when glucose exceeds 8-10 mM.

The membrane's selective permeability creates the foundation for cellular specialization, with each cell type expressing 200-400 different transport proteins to maintain its unique internal environment and respond to specific physiological demands.

🔬 Cellular Command Center: The Membrane's Molecular Machinery

⚡ Ion Channel Architecture: The Cellular Electrical Grid

Channel Classification and Gating Mechanisms

Ion channels represent the fastest transport systems in biology, achieving remarkable selectivity through sophisticated molecular filters:

  • Voltage-Gated Channels

    • Activation threshold: -55 to -40 mV (Na⁺ channels)
    • Opening kinetics: 0.1-1 millisecond (fast channels)
    • Selectivity ratios: Na⁺:K⁺ = 10:1, Ca²⁺:Na⁺ = 1000:1
      • S4 voltage sensor: 4-7 positive charges per domain
      • Inactivation gate: 1-5 milliseconds (fast), 100-1000 ms (slow)
  • Ligand-Gated Channels

    • Binding affinity: nM to μM range for physiological ligands
    • Channel conductance: 1-50 pS (single channel)
    • Desensitization time: 10-100 milliseconds (AMPA), seconds (NMDA)
      • Nicotinic AChR: 2 ACh molecules required for opening
      • GABA-A: 2-3 GABA molecules for maximal activation

📌 Remember: VLIC - Voltage Ligand Inward-rectifier Calcium-activated. The four major channel families each use different gating mechanisms: voltage sensors (S4 domain), ligand binding (extracellular or intracellular), membrane voltage (rectification), and calcium concentration (μM to mM range).

Clinical Pearl: Channel mutations cause >400 human diseases. Voltage-gated Na⁺ channel mutations (SCN5A) cause Long QT syndrome type 3, where gain-of-function mutations increase late Na⁺ current by 2-5%, prolonging action potential duration and triggering torsades de pointes arrhythmias.

💡 Master This: Channel selectivity depends on pore diameter and charge distribution. K⁺ channels achieve 10,000:1 selectivity over Na⁺ despite K⁺ being larger, because the selectivity filter (2.8 Å diameter) forces K⁺ to shed its hydration shell, while Na⁺ cannot form stable interactions with the carbonyl oxygens.

Channel dysfunction underlies neurological, cardiac, and muscular diseases, making these molecular machines prime therapeutic targets for >30% of current pharmaceuticals.

⚡ Ion Channel Architecture: The Cellular Electrical Grid

🚛 Carrier Protein Logistics: The Cellular Supply Chain

Carrier-Mediated Transport Mechanisms

Carrier proteins achieve selective transport through induced-fit binding and conformational cycling:

  • Facilitated Diffusion Carriers

    • GLUT family: 14 isoforms with tissue-specific distribution
    • Transport rates: 10⁴-10⁶ molecules/second per carrier
    • Km values: GLUT1 (1-2 mM), GLUT2 (15-20 mM), GLUT4 (5 mM)
      • Brain glucose transport: Km = 1.5 mM (below plasma glucose)
      • Muscle glucose uptake: insulin-stimulated 10-fold increase
  • Active Transport Systems

    • Na⁺/K⁺-ATPase: 3 Na⁺ out, 2 K⁺ in per ATP hydrolysis
    • ATP consumption: 25-40% of cellular energy at rest
    • Pump density: 800-1000 pumps/μm² in kidney tubules
      • Cardiac glycosides: IC₅₀ = 0.1-1 μM for pump inhibition
      • Pump turnover: 100-200 cycles/second at physiological conditions

📌 Remember: SKAT - Sodium K+ ATPase Transports. The pump moves 3 Na⁺ OUT and 2 K⁺ IN using 1 ATP, creating electrogenic transport that contributes -5 to -10 mV to resting potential and maintains 140 mM K⁺ inside vs 5 mM outside.

TransporterSubstrateKm (mM)Vmax (relative)Tissue DistributionClinical Significance
GLUT1Glucose1-2HighBrain, RBCBlood-brain barrier
GLUT2Glucose15-20Very HighLiver, pancreasGlucose sensing
GLUT4Glucose5HighMuscle, adiposeInsulin-responsive
SGLT1Glucose + Na⁺0.5MediumIntestine, kidneyGlucose absorption
MCT1Lactate3-5MediumMuscle, brainLactate transport

💡 Master This: Secondary active transport couples favorable ion gradients to drive unfavorable substrate transport. SGLT1 uses the Na⁺ gradient (140 mM out, 10 mM in) to concentrate glucose 40-fold above plasma levels, achieving 99% glucose absorption efficiency in the small intestine.

Carrier protein coordination creates integrated transport networks that respond dynamically to cellular energy status, hormonal signals, and metabolic demands.

🚛 Carrier Protein Logistics: The Cellular Supply Chain

🎯 Transport Integration: The Cellular Traffic Control System

Coordinated Transport Networks

Cellular transport integration requires precise coordination between multiple protein families:

  • Epithelial Transport Coordination

    • Apical membrane: SGLT1 (glucose uptake) + CFTR (Cl⁻ secretion)
    • Basolateral membrane: GLUT2 (glucose exit) + Na⁺/K⁺-ATPase (driving force)
    • Transport efficiency: >95% glucose absorption, <2% fecal loss
      • Transcellular glucose flux: 300-500 mg/min during feeding
      • Na⁺ gradient maintenance: 10:1 ratio across apical membrane
  • Neuronal Membrane Integration

    • Action potential: Na⁺ channels (depolarization) + K⁺ channels (repolarization)
    • Recovery phase: Na⁺/K⁺-ATPase + Ca²⁺-ATPase restoration
    • Synaptic transmission: Ca²⁺ channels + neurotransmitter transporters
      • Conduction velocity: 0.5-120 m/s depending on myelination
      • Synaptic delay: 0.3-0.5 ms for chemical transmission

📌 Remember: TEAM - Transcellular Epithelial Apical Membrane. Epithelial transport requires apical uptake (SGLT1, ENaC), basolateral exit (GLUT2, Na⁺/K⁺-ATPase), tight junction integrity (>1000 Ω·cm²), and driving force maintenance (Na⁺ gradient).

Clinical Pearl: Transport integration failure causes cystic fibrosis. CFTR mutations disrupt Cl⁻ secretion, reducing Na⁺ and water efflux by 70-80%. This creates thick mucus (water content <95% vs normal >98%), impaired mucociliary clearance, and bacterial colonization leading to progressive lung disease.

💡 Master This: Membrane potential reflects integrated transport activity. Resting potential (-70 mV) results from K⁺ permeability (40-fold > Na⁺), Na⁺/K⁺-ATPase electrogenic activity (-5 to -10 mV), and Cl⁻ distribution following Donnan equilibrium with impermeant anions.

Transport integration enables cellular specialization while maintaining system-wide homeostasis through coordinated molecular networks.

🎯 Transport Integration: The Cellular Traffic Control System

⚖️ Clinical Transport Disorders: When Molecular Machines Malfunction

Evidence-Based Treatment Algorithms

Transport disorders require mechanism-specific therapeutic approaches:

  • Channelopathy Management

    • Long QT syndrome: β-blockers reduce arrhythmic events by 70-80%
    • Epilepsy syndromes: Na⁺ channel blockers achieve seizure freedom in 60-70%
    • Periodic paralysis: Carbonic anhydrase inhibitors prevent attacks in 80-90%
      • Genetic testing: >95% sensitivity for known mutations
      • Treatment response: genotype-specific efficacy patterns
  • Transporter Disease Therapy

    • Cystic fibrosis: CFTR modulators improve lung function by 10-15%
    • Diabetes mellitus: SGLT2 inhibitors reduce cardiovascular events by 25-30%
    • Hypertension: Thiazides block NCC transporters, reducing BP by 15-20 mmHg
      • Personalized dosing: pharmacogenomic testing improves outcomes
      • Combination therapy: synergistic effects with multiple targets

📌 Remember: CITE - Channelopathy Identification Treatment Efficacy. Genetic testing identifies specific mutations (>400 known), guides targeted therapy (mechanism-based), monitors treatment response (biomarkers), and predicts family risk (genetic counseling).

DisorderDefective ProteinInheritancePrevalenceTreatmentEfficacy (%)
Cystic FibrosisCFTRAR1:2500Ivacaftor/Lumacaftor60-80
Long QT Type 1KCNQ1AD1:2000β-blockers70-85
Bartter SyndromeNKCC2AR1:1,000,000K⁺/Mg²⁺ supplements50-70
Gitelman SyndromeNCCAR1:40,000Mg²⁺ replacement60-80
Liddle SyndromeENaCADRareAmiloride80-95

💡 Master This: Transport disorder severity correlates with residual protein function. Class I-III CFTR mutations (no functional protein) cause severe disease with pancreatic insufficiency, while Class IV-V mutations (reduced function) cause milder phenotypes with preserved pancreatic function and better prognosis.

Evidence-based transport disorder management requires genetic diagnosis, mechanism-specific therapy, and long-term monitoring to optimize patient outcomes.

⚖️ Clinical Transport Disorders: When Molecular Machines Malfunction

🔗 Advanced Transport Networks: The Cellular Internet

Multi-System Transport Integration

Advanced cellular transport requires coordination across multiple membrane systems:

  • Organellar Transport Networks

    • Mitochondrial import: >1000 proteins via TOM/TIM complexes
    • ER protein folding: 30% of cellular proteins processed
    • Golgi modification: >200 enzymes for post-translational processing
      • Import rates: 10-100 proteins/second per mitochondrion
      • Quality control: >95% fidelity for protein targeting
  • Vesicular Trafficking Systems

    • Endocytosis: 10⁶ vesicles/hour in active cells
    • Exocytosis: regulated secretion within 1-2 milliseconds
    • Membrane recycling: complete turnover every 30-60 minutes
      • SNARE proteins: >35 family members for specificity
      • Rab GTPases: >60 isoforms for vesicle targeting

📌 Remember: MOVE - Mitochondrial Organellar Vesicular Endoplasmic. Advanced transport integrates mitochondrial biogenesis (protein import), organellar communication (contact sites), vesicular trafficking (SNARE-mediated), and ER-Golgi transport (COPII/COPI vesicles).

Clinical Pearl: Transport network dysfunction causes neurodegenerative diseases. Alzheimer's disease involves APP processing defects in endosomal compartments, leading to Aβ accumulation. Parkinson's disease results from α-synuclein aggregation disrupting vesicular transport, causing dopaminergic neuron death.

💡 Master This: Membrane contact sites enable non-vesicular transport between organelles. ER-mitochondria contacts (10-30 nm gaps) facilitate Ca²⁺ transfer, lipid synthesis, and metabolic coordination. >20% of mitochondrial surface** contacts ER, creating metabolic microdomains for specialized functions.

Advanced transport networks create cellular intelligence through coordinated molecular systems that enable adaptive responses to environmental challenges.

🔗 Advanced Transport Networks: The Cellular Internet

🎯 Transport Mastery: The Clinical Command Center

Essential Clinical Arsenal

Master these quantitative thresholds for immediate clinical application:

  • Critical Transport Values

    • Membrane potential: -70 mV (normal), >-50 mV (depolarized)
    • Na⁺/K⁺ ratio: 1:30 (intracellular), 30:1 (extracellular)
    • Ca²⁺ gradient: 10,000:1 (outside:inside), 100 nM resting
      • ATP consumption: 25-40% for ion pumps
      • Transport capacity: 10⁶ molecules/second per carrier
  • Diagnostic Pattern Recognition

    • Channelopathies: QT prolongation (>450 ms), seizure patterns
    • Transport defects: electrolyte imbalances, metabolic acidosis
    • Membrane disorders: hemolysis, muscle weakness, arrhythmias

📌 Remember: MASTER - Membrane ATP Selectivity Threshold Electrochemical Regulation. Clinical mastery requires understanding membrane integrity (osmotic fragility), ATP dependence (metabolic status), selectivity (ion specificity), threshold (activation potentials), electrochemical (driving forces), and regulation (hormonal control).

Clinical ScenarioTransport DefectKey FindingDiagnostic TestTreatmentOutcome
Prolonged QTKCNQ1 mutationQTc >480 msGenetic testingβ-blockers80% event reduction
Recurrent UTICFTR dysfunctionThick secretionsSweat chlorideCFTR modulators60% improvement
Muscle WeaknessCa²⁺ channel defectPeriodic paralysisEMG changesAcetazolamide90% attack prevention
Renal StonesNCC mutationHypokalemiaGenetic analysisK⁺ supplementsSymptom control
Cardiac ArrestNa⁺ channel blockWide QRSDrug levelsSodium bicarbonateRhythm restoration

💡 Master This: Therapeutic targeting of transport systems requires mechanism-specific approaches. CFTR potentiators (ivacaftor) increase channel open probability, correctors (lumacaftor) improve protein folding, and amplifiers increase protein expression, achieving synergistic effects through combination therapy.

Transport mastery enables precision diagnosis, targeted therapy, and optimal outcomes through systematic application of molecular principles to clinical practice.

🎯 Transport Mastery: The Clinical Command Center

Practice Questions: Cellular Physiology

Test your understanding with these related questions

Which electrolyte imbalance causes prolonged QT interval?

1 of 5

Flashcards: Cellular Physiology

1/10

_____ are glial cells that help mediate K+ ion metabolism

TAP TO REVEAL ANSWER

_____ are glial cells that help mediate K+ ion metabolism

Astrocytes

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial